Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review

Linda Rider

According to Forbes, in October 2020, cannabidiol (CBD) sales in the United States reached $4.2 billion after the federal government legalized hemp-derived CBD in 2018 [1]. In addition, the World Health Organization (WHO) in 2019 re-classified CBD and <0.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of delta-9-tetrahydrocannabinol (THC) as not under international control and recognized its […]